Trademarkia Logo

Australia

AU$
Trademark Search
GVOKE

View On IPO.GOV.AU

GVOKE
Protected: Registered/protected

Last updated on 30 Dec 2020

Owner Info

Xeris Pharmaceuticals, Inc.

180 N LaSalle Street, Suite 1600

Chicago IL 60601, UNITED STATES OF AMERICA

Serial Number

2004108 filed on 19 Dec 2018

Correspondent

Tracy-Gene G. Durkin of Sterne, Kessler, Goldstein & Fox P.L.L.C.

1100 New York Avenue, NW,

Washington DC 20005,

UNITED STATES OF AMERICA

GVOKE

Classification Information

Class [005]
Pharmaceutical products for the treatment of diabetes and metabolic diseases; pharmaceutical products for the treatment of diabetes and metabolic dise Read More

Mark Details

Serial Number

2004108

Registered On

19 Dec 2018

Renewal On

19 Dec 2028

Mark Type

WORD

Priority Claim (Convention Details)

Date

22 Jun 2018

Mark Type

US

Legal History

Show more

Status DateAction Taken
30th Dec 2020International Registration in Australia Protected After Adverse (No amendments) correspondence sent
29th Dec 2020International Registration in Australia Protected After Adverse (No amendments) correspondence sent
29th Dec 2020IP Right Registration Published
29th Dec 2020Status change to Registered/Protected
21st Oct 2020Application Accepted correspondence sent
21st Oct 2020Application Accepted correspondence sent
20th Oct 2020IP Right has been Examined
20th Oct 2020IP Right Acceptance Published
20th Oct 2020Status change to Accepted
16th Oct 2020Examination Response Received